Skip to main content
. Author manuscript; available in PMC: 2022 Apr 11.
Published in final edited form as: Quant Biol. 2021 Jun;9(2):216–227. doi: 10.15302/j-qb-021-0248

Table 2.

Significant genes in TADA-R analysis of CHD case trios

Gene BF_LoF BF_D-Mis FDR Jin (2017) Annotation
CHD7 1.76E + 16 3.25E−01 0.001 1 H-CHD
KMT2D 3.97E + 16 2.52E + 13 0.001 2 H-CHD
PTPN11 5.32E−01 1.24E + 17 0.001 3 H-CHD
RBFOX2 1.63E + 04 1.87 0.001 6
GDF1 7.51E + 03 8.23E + 09 0.001 H-CHD
POGZ 2.72E + 02 4.39 0.020 23
ACTB 2.66E + 01 3.80E + 01 0.024 H-CHD
CYP21A2 3.56 7.13 0.059
ADIPOQ 5.11E-02 2.23E + 08 0.059
NSD1 2.94E + 03 9.85E + 01 0.059 15 H-CHD
SULF1 3.01E−02 2.26E + 14 0.059
RPL5 7.79E + 03 1.12 0.059 H-CHD
AKAP12 1.49E + 02 8.47E−01 0.059
NOTCH1 3.39E + 06 1.01E + 26 0.059 5 H-CHD
SMAD2 1.39E + 02 9.12E + 02 0.096 19

TADA-R analysis was performed on 2,645 CHD case trios. Bayes factor values were computed separately for LoF and D-Mis variants (shown as BF_LoF and BF_D-Mis). We annotated significant genes on whether they are among the top 25 genes identified by Jin et al. or known human CHD genes (H-CHD).